Home  |  Archive  |  AJA @ Nature  |  Online Submission  |  News & Events  |  Subscribe  |  APFA  |  Society  |  Links  |  Contact Us  |  中文版

Effect of renewed SS-cream on spinal somatosensory evoked potential in rabbits

Long Tian1, Zhong-Cheng Xin2, Hua Xin2, Jie Fu2, Yi-Ming Yuan2, Wu-Jiang Liu2, Chun Yang2

1Department of Urology, Wuhan University Renmin Hospital, Wuhan 430060, China
2Department of Urology, Peking University First Hospital, Beijing 100034, China

Asian J Androl 2004 Mar; 615-18


Keywords: renewed SS-cream; premature ejaculation; spinal somatosensory evoked potential
Abstract

Aim: The effect of a renewed SS-cream (RSSC) on the treatment of premature ejaculation (PE) was evaluated and compared with the original SS-cream (OSSC). Methods: Sixty male white New Zealand rabbits, weighing 2.5kg-3.0 kg, were divided at random into 3 groups: the RSSC, OSSC and placebo groups. The spinal somatosensory evoked potential (SSEP) elicited by electric stimulation of the glans penis with disk electrode was investigated with an electrophysiograph (Poseidomn, Shanghai, China) before and 10, 30 and 60 min after drug or placebo application on the glans. The Onset and the N1 latencies and the amplitude of SSEP were recorded and analyzed. Results: There was no significant difference (P>0.05) in the mean Onset and N1 latency of SSEP among the 3 groups before drug application. Compared with the pre-application value, the mean Onset and N1 latencies in the RSSC and OSSC groups were significantly prolonged at 10, 30 and 60 min after treatment (P<0.05), while they were not significantly changed (P>0.05) in the placebo group. The mean Onset latency of RSSC at 10 and 30 min and that of OSSC at 30 min were significantly delayed (P<0.05) compared with the placebo group. The mean N1 latency of RSSC at 30 and 60 min and that of OSSC group at 30 min were also significantly delayed (P<0.05). Conclusion: RSSC delays the latencies of SSEP, suggesting a local desensitizing effect on the sensory receptor of the glans penis dorsal nerve, which provides the potential for PE treatment. The desensitizing effect of RSSC is higher than that of OSSC.

1 Introduction

Premature ejaculation (PE) is the most common type of ejaculatory dysfunction; approximately 35 %-70 % of men experienced PE at certain stage of their sexual life [1]. PE is defined as the inability to delay ejaculation sufficiently to enjoy lovemaking and the persistent or recurrent occurrence of ejaculation with minimal sexual stimulation before, during or shortly after penetration; the orgasm and ejaculation occur before the desired moment [2]. Therefore, it significantly influences the patient's and the partner's sexual satisfaction and thus their life quality [3].

Despite the high prevalence of PE in men, little research has directly focused on the mechanism of its development. Traditionally, it was thought that in the majority of patients, PE was caused by psychological factors, including anxiety, unresolved conflicts, marital difficulties, infrequent intercourse, etc.[4] and the primary treatment involved psychological measures, such as penile-squeezing and counseling [1]. Recently, neurobiological studies suggest that PE may be a neurological and not a psychological disorder [5]. Long continued PE is usually related to faulty central serotonergic neurotransmission conditioned by hereditary factors. Lately, psychotropic medicines, such as selective serotonin re-take inhibitors (SSRIs), were found to be highly effective in delaying ejaculation [6], however, these dugs may decreased the sexual desire and cause erectile difficulty and delayed ejaculation [7, 8]. Rowland et al [9] and Xin et al [10, 11] indicated that primary PE patients showed a lower penile sensory threshold and a higher sensory nerve excitability compared to the controls. The condition is reversed by the application of a topical agent, the SS-cream on the glans penis. The SS-cream is a mixture of nine traditional medicines, including Korean ginseng, bufonoid venom, cinnamon, etc. which have been shown to possess a local desensitizing effect and proved to be safe and effective for PE treatment upon local application on the glans penis [12-15]. Pharmacological research showed that it increased the penile sensory threshold and delayed the GPSEP latency [13, 14]. However, some patients complained of its unpleasant smell and color. It has also been reported that a local anesthetic combination (lidocaine and prilocaine) has a delaying effect on intravaginal ejaculation latency time (IVELT) through desensitizing the glans, but it may cause numbness of the glans and prolong the waiting time [16, 17].

The spinal somatosensory evoked potential (SSEP) has been observed to study the activity of the peripheral penile sensory nerves. Traditionally, the dorsal nerve somatosensory evoked potential (DNSEP) was recorded by stimulating the penile shaft with a ring electrode [18]. However, as the glans penis constitutes the primary erogenic area, we examined the glans penis somatosensory evoked potential (GPSEP) and indicated that GPSEP was more specific to evaluate the sensory nerve function then DNSEP [11].

The renewed SS-cream (RSSC) is a new topical agent composed of the two main components of the original SS-cream (OSSC), Korean ginseng and bufonoid venom, mixed in a hydrobase with a special enhancer without smell and color [19, 20]. RSSC has been shown to be an excellent desensitizing agent.

The present invesgation was designed to study the mechanism of RSSC (and OSSC) in the treatment of PE.

2 Materials and methods

2.1 Drugs

The ingredients of SS-cream were indicated in our previous paper [21]. The RSSC contains Bufonoid venom, Korean Ginseng extract and a hydrobase with a special enhancer consisting of ethylalcohol, propylene glycol monolaurate, N-methyl pyrrolidinone, diethylene glycol monoethyl ether, carbopol 940 and sodium hydroxide. The RSSC, the OSSC and the placebo (provided by the CJ Co. LTD, Seoul, Korea) at 0.2 mg each were enveloped separately in paper bags printed only with their allocation numbers.

Electrophysiologic recordings were performed using an electromyograph (Poseidomn Co., Shanghai, China).

2.2 Animals

Sixty male White New Zealand rabbits, weighing
2.5-3.0 kg, were divided at random into the RSSC, OSSC and placebo groups of 20 animals each. The Principles of Laboratory Animal Care (NIH publication No 86-23, revised 1985) as well as the Chinese Government Rule on the Protection of Laboratory Animals were followed.

2.3 Pudendal nerve SSEP

The active recording electrode was applied at L1 and the reference electrode, L5 [22]. Ground electrode was placed between the stimulating and the recording electrodes. Rectangular stimuli of 0.1 msec was applied to the glans penis with disk electrode; the intensity was gradually increased from 2 to 8 mA until SSEP responses were induced. The sensitivity of the amplifiers was 10 mV and the bandpass from 3 Hz to 2 KHz. The SSEP tracings represented the average of 300 responses.

The latency of the SSEP responses was measured at the onset of the initial negative deflection (Onset latency) and the first negative peak (N1 latency); the amplitude was measured from peak to peak.

2.4 Drug application

After anesthesia and correct electrode connection, the SSEP were first stimulated. Then the drug or placebo (0.2 mg) was applied on the glans with mild rubbing for 1 min. 10, 30 and 60 min later, SSEP were recorded. In order to avoid subjective bias, the technicians were only informed of the allocation number and not the drug name.

2.5 Data processing

Data were expresses in meanSD. The one-way ANOVA test and the Student t-test were used for statistical ananysis. P<0.05 was considered significant.

3 Results

The SSEP was successfully elicited before and after drug or placebo application (Figure 1). Before applica-tion, the mean Onset latency of the 3 groups showed no significant difference (P>0.05). After application (10 and 30 min), it was significantly delayed (P<0.05) in the RSSC and OSSC groups, while no significant change was noted in the placebo group (P>0.05). Comparing with the placebo group, the mean Onset latency of the RSSC (at 10 and 30 min) and the OSSC group (at 30 min) were significantly delayed (P<0.05) (Table 1).

Figure 1. Representative tracing of spinal sensory evoked potential (SSEP) elicited by electric stimulation at the glans penis in rabbit. Electric stimulation was applied before and 10, 30 and 60 min after application of RSSC (0.2 mg) on the glans penis. ONSET: Onset latency; N1: N1 latency.

Table 1. SSEP Onset latency (ms). bP<0.05, compared with pre-application, eP<0.05, compared with placebo.

 

Pre-application

Post-application

10min

30 min

60min

Placebo

10.681.17

10.721.24

10.701.16

10.801.19

RSSC

10.591.42

11.311.43b,e

11.781.70b,e

11.481.70

OSSC

10.421.19

10.941.47b

11.661.70b,e

11.251.75

Before drug or placebo application, the mean N1 latency of the three groups showed no significant difference (P>0.05). After application (10, 30 and 60 min), it was significantly delayed in the RSSC and OSSC groups (P<0.05), while the placebo group had no significant change (P>0.05). Comparing with the placebo group, the mean N1 latency of the RSSC group (at 30 and 60 min) and OSSC (at 30 min) were significantly delayed (P<0.05) (Table 2).

Table 2. SSEP N1 latency (ms). bP<0.05, compared with pre-application, eP<0.05, compared with placebo.

 

Pre-application

Post-application

10min

30 min

60min

Placebo

12.911.44

13.101.64

13.061.42

13.211.32

RSSC

13.081.37

14.081.46b

14.171.43b,e

14.151.46b,e

OSSC

13.021.12

13.741.90b

14.201.37b,e

13.971.33b

Both the RSSC and OSSC groups showed a tendency of a decrease in SSEP amplitude, but statistically insignificant (P>0.05) (data not listed).

4 Discussion

Although some psychotropic medications(phenothi-azines and antiaxiolytics) are highly efficacious for delaying ejaculation, however, they have their limitation because of systematic [7] and sexual function side effects [8].

It has been indicated that in PE patients the sensory threshold of the glans penis is significantly lowered [10] and the GPSEP latency significantly delayed compared with the controls [11]. In recent studies, topical administration of certain desensitizing drugs had satisfactory results for PE treatment [16, 17]. These results suggested that penile hypersensitivity and/or hyperexcitability may be the organic basis of PE. Another study evaluated the penile sensitivity of 18 patients with a long history of PE and 15 controls and suggested that penile hypersensitivity does not appear to be a major factor contributing to premature ejaculation [22]. The inconsistency may be due to the limited sample size of that study and/or the difference in patient entry criteria.

In the study on DNSEP, cortical recording via surface electrodes is employed and in animal study, intravenous anesthesia has to be used, therefore, may influence on cortical evoked potential [18]. In this study, GPSEP was observed with the stimulating electrode at the glans and the recording electrodes at L1 and L5. It may avoid the influence of intra-venous anesthesia on the cortical evoked potential, therefore, appears to be more appropriate for assessing the sensory nerve function of the glans.

The present study indicated that the local application of RSSC significantly delayed the Onset and N1 latencies of SSEP: the Onset latencies of RSSC at 10 and 30 min and the N1 latencies at 30 and 60 min were significantly delayed. These results show that the local desensitizing effect of RSSC will be initiated at 10 min after application and maintained at least for 50 min. For future clinical application, PE patients may be advised to use RSSC 10 min before intercourse and a maintainence period of 60 min will be enough for lovemaking. Both the Onest and N1 latencies of SSEP had their highest value at 30 min after application, suggesting that RSSC had its peak action time at 30 min. The OSSC also significantly delayed the SSEP Onset and N1 latencies, but only at 30 min after application

In conclusion, RSSC delays the latencies of SSEP more effectively than OSSC, suggesting a better effect in the treatment of PE.

References

[1] Jannini EA, Simonelli C, Lenzi A. Sexological approach to ejaculatory dysfunction. Int J Androl 2002; 25: 317-23.
[2] Rowland DL, Cooper SE, Schneider M. Defining premature ejaculation for experimental and clinical investigations. Arch Sex Behav 2001; 30: 235-53.
[3] Symonds T, Roblin D, Hart K, Althof S. How does premature ejaculation impact a man's life? J Sex Marital Ther 2003; 29:361-70.
[4] Metz ME, Pryor JL. Premature ejaculation: a psychophysiological approach for assessment and management. J Sex Marital Ther 2000; 26: 293-320.
[5] Waldinger MD. The neurobiological approach to premature ejaculation. J Urol 2002; 168: 2359-67.
[6] Waldinger MD, van De Plas A, Pattij T, van Oorschot R, Coolen LM, Veening JG, et al. The selective serotonin re-uptake inhibitors fluvoxamine and paroxetine differ in sexual inhibitory effects after chronic treatment. Psychopharmacology (Berl). 2002; 160: 283-9.
[7] Waldinger MD, Hengeveld MW, Zwinderman AH. Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study. Am J Psychiatry 1994; 151(9): 1377-9.
[8] Waldinger MD. Olivier, B. Selective serotonin reuptake inhibitors (SSRIs) and sexual side effects: differences in delaying ejaculation. In: Sacchetti E, Spano P, editors. Fluvoxamine: Established and Emerging Roles in Psychiatric Disorders. Advances in Preclinical and Clinical Psychiatry. v 1. Milan: Excerpta Medica; 2000. p. 117-30.
[9] Rowland DL, Haensel SM, Blom JH, Slob AK. Penile sensitivity in men with premature ejaculation and erectile dysfunction. J Sex Marital Ther 1993; 19: 189-97.
[10] Xin ZC, Chung WS, Choi YD, Seong DH, Choi YJ, Choi HK. Penile sensitivity in patients with primary premature ejaculation. J Urol 1996; 156: 979-81..
[11] Xin ZC, Choi YD, Rha KH, Choi HK. Somatosensory evoked potentials in patients with primary premature ejaculation. J Urol 1997; 158: 451-5.
[12] Xin ZC, Choi YD, Lee WH, Choi YJ, Yang WJ, Choi HK, et al. Penile vibratory threshold changes with various doses of SS-cream in patients with primary premature ejaculation. Yonsei Med J 2000; 41: 29-33.
[13] Xin ZC, Choi YD, Seong DH, Choi HK. Sensory evoked potiantial and effect of SS-cream in premature ejaculation. Yonsei Med J 1995; 36: 397-401.
[14] Xin ZC, Choi YD, Lee SH, Choi HK. Efficacy of topical agent SS-cream in the treatment of premature ejaculation: preliminary clinical studies. Yonsei Med J 1997; 38: 91-5.
[15] Choi HK, Jung GW, Moon KH, Xin ZC, Choi YD, Lee WH, et al. Clinical study of SS-cream in patients with lifelong premature ejaculation. Urology 2000; 55: 257-61.
[16] Henry R, Morales A. Topical lidocaine-prilocaine spray for the treatment of premature ejaculation: a proof of concept study. Int J Impot Res 2003; 15: 277-81.
[17] Atikeler MK, Gecit I, Senol FA. Optimum usage of prilocaine-lidocaine cream in premature ejaculation. Andrologia 2002; 34: 356-9.
[18] Bradley WE, Farrell DF, Ojemann GA. Human cerebrocortical potentials evoked by stimulation of the dorsal nerve of the penis. Somatosens Mot Res 1998; 15: 118-27.
[19] Yoshida S, Kamano Y, Sakai T. Studies on the surface anesthetic activity of bufadienolides isolated from Chan
su. Chem Pharm Bull 1976; 24: 1714-7.
[20] Xin ZC, Choi YD, Choi HK. The effects of SS-cream and its individual components on rabbit corpus cavernosal muscles.Yonsei Med J 1996; 37: 312-8.
[21] Paick JS, Jeong H, Park MS. Penile sensitivity in men with premature ejaculation. Int J Impot Res 1998; 10: 247-50.
[22] Jou IM, Chu KS, Chen HH, Chang PJ, Tsai YC. The effects of intrathecal tramadol on spinal somatosensory-evoked potentials and motor-evoked responses in rats. Anesth Analg 2003; 96: 783-8.


Correspondence to: Prof. Zhong-Cheng Xin, Department of Urology, Peking University First Hospital, 8 Xishiku Street, Xicheng District, Beijing 100034, China.
Tel: +86-10-6655 1122 ext. 2843 or 2955, Fax: +86-10-6612 9625
E-mail: xinzc@bjmu.edu.cn
Received 2003-07-18 Accepted 2004-02-07